Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have been assigned an average rating of “Moderate Buy” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $130.8750.

Several analysts have issued reports on ADUS shares. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Finally, Barclays upped their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th.

Insider Activity

In other news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider directly owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Leeward Investments LLC MA raised its position in Addus HomeCare by 9.4% during the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock valued at $11,318,000 after purchasing an additional 10,414 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Addus HomeCare by 11.3% during the first quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after buying an additional 32,714 shares during the period. Vanguard Group Inc. raised its holdings in shares of Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after acquiring an additional 10,501 shares in the last quarter. Summit Creek Advisors LLC purchased a new stake in Addus HomeCare in the second quarter worth about $8,552,000. Finally, SG Americas Securities LLC grew its holdings in Addus HomeCare by 176.0% during the 1st quarter. SG Americas Securities LLC now owns 27,303 shares of the company’s stock worth $2,557,000 after acquiring an additional 17,411 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Stock Performance

Shares of ADUS opened at $120.81 on Monday. The company’s fifty day simple moving average is $109.47 and its 200-day simple moving average is $102.48. The company has a market cap of $2.26 billion, a P/E ratio of 21.19, a P/E/G ratio of 1.62 and a beta of 0.87. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare has a twelve month low of $87.95 and a twelve month high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to analysts’ expectations of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.49 EPS. As a group, analysts expect that Addus HomeCare will post 6.29 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.